In a groundbreaking move to combat Alzheimer’s disease, an experimental drug is set to be tested on healthy individuals in their middle ages, specifically those identified as having an elevated risk of developing the condition. This initiative aims to intervene before the onset of dementia symptoms.
The trial, spearheaded by an NHS trust, forms part of a larger international effort to prevent dementia by targeting individuals who currently exhibit no memory loss but may still be vulnerable to cognitive decline in the future.
Fonte/Origem: https://www.theguardian.com/society/2026/sep/05/alzheimers-trial-drug-dementia